Raloxifene and anti-estrogenic Gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem like cells

Studies suggest that estrogen plays a contributing role in colorectal cancer (CRC). This project examined the preventive effects of raloxifene, a selective estrogen receptor modulator (SERM), and gonadorelin, an anti-estrogenic drug, in female Apc(Min/+) mouse intestinal tumorigenesis. Six-week-old...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Janakiram, Naveena B., Mohammed, Altaf, Brewer, Misty, Bryant, Taylor, Biddick, Laura, Lightfoot, Stan, Pathuri, Gopal, Gali, Hariprasad, Rao, Chinthalapally V.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3951612/
https://ncbi.nlm.nih.gov/pubmed/24431404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-13-0345
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky